Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 33
Filter
Add more filters










Publication year range
1.
Biol Trace Elem Res ; 196(2): 517-527, 2020 Aug.
Article in English | MEDLINE | ID: mdl-31691895

ABSTRACT

The protective effect of caffeic acid on ferric-induced pancreatic injury was investigated using ex vivo and in silico models. Incubation of pancreatic tissues with Fe2+ led to significant depleted levels of glutathione (GSH) and SOD and catalase activities, with concomitant elevated levels of malondialdehyde (MDA) and nitric oxide (NO) and acetylcholinesterase and α-chymotrypsin activities. Treatment with caffeic acid led to significant reversion of these levels and activities. Molecular docking revealed a higher binding affinity of caffeic acid with acetylcholinesterase via hydrogen bonding, Pi-Pi stacking, and Van der Waals interactions. FTIR spectroscopy of pancreatic metabolite revealed little or no effect by caffeic acid on functional groups in ferric-induced injured pancreas. The LC-MS analysis of the metabolites revealed Fe2+ caused a 20% depletion of the normal metabolites, with concomitant generation of glyceraldehyde and 3,4-dihydroxymandelaldehyde. Treatment with caffeic acid led to the restoration of TG(22:4(7Z,10Z,13Z,16Z)/24:0/22:5(7Z,10Z,13Z,16Z,19Z)) and dTDP-D-glucose, while depleting glyceraldehyde as well as activating gluconeogenesis. These results indicate the ability of caffeic acid to protect against ferric toxicity by exacerbating antioxidative activities, with concomitant inhibition of MDA and NO levels while deactivating metabolic pathways linked to oxidative stress.


Subject(s)
Antioxidants/pharmacology , Caffeic Acids/pharmacology , Cholinergic Agents/metabolism , Ferrous Compounds/antagonists & inhibitors , Pancreas/drug effects , Protective Agents/pharmacology , Animals , Antioxidants/chemistry , Caffeic Acids/chemistry , Ferrous Compounds/pharmacology , Male , Molecular Docking Simulation , Oxidative Stress/drug effects , Pancreas/injuries , Pancreas/metabolism , Protective Agents/chemistry , Proteolysis/drug effects , Rats , Rats, Sprague-Dawley
2.
Bioorg Med Chem ; 26(18): 5037-5044, 2018 10 01.
Article in English | MEDLINE | ID: mdl-30196978

ABSTRACT

Tetrahydroberberine (THB), otherwise known as canadine, is a natural alkaloid showing significant pharmacological properties and antioxidant protection against oxidative damage. Herein, we synthetized structurally complex THB analogues, namely pyrrolino-tetrahydroberberines (PTHBs) 4a-g, containing the pyrrolino[2,3-b]pyridine system, by means of the reactions of 1,2-diaza-1,3-dienes and 7,8-dihydroberberine. Aim of the study was to explore the in vitro antioxidant properties of PTHBs in comparison to THB thus to identify the most effective against free radical-induced oxidative injury, by using three different antioxidant tests: the ORAC method, the DNA nicking assay, and the DCFH-DA cellular assay. As a result, PTHB 4d emerged among the other THB analogues by exhibiting the best antioxidant properties. First, it was the only compound having an ORAC value completely comparable to that of THB, indicating the same ability to neutralize peroxyl radicals. Secondly, 4d showed an even better antioxidant capacity than THB in protecting DNA against ferrous ion-induced strand breaks. These observations were also confirmed in NCTC-2544 human keratinocytes exposed to hydrogen peroxide. Indeed, 4d protected cells against oxidation more efficiently than THB both in the short (1 and 3 h) and long (24 h) period of incubation, possibly suggesting increased cell membrane permeability and/or intracellular stability of 4d as compared to THB.


Subject(s)
Antioxidants/pharmacology , Berberine/analogs & derivatives , Pyrroles/pharmacology , Antioxidants/chemical synthesis , Antioxidants/chemistry , Berberine/chemical synthesis , Berberine/chemistry , Berberine/pharmacology , Cell Line , Cell Proliferation/drug effects , Cell Survival/drug effects , DNA/drug effects , DNA Breaks , Dose-Response Relationship, Drug , Ferrous Compounds/antagonists & inhibitors , Ferrous Compounds/pharmacology , Free Radicals/antagonists & inhibitors , Free Radicals/pharmacology , Humans , Hydrogen Peroxide/pharmacology , Keratinocytes/drug effects , Keratinocytes/metabolism , Molecular Structure , Pyrroles/chemical synthesis , Pyrroles/chemistry , Structure-Activity Relationship
3.
Biometals ; 30(4): 549-558, 2017 08.
Article in English | MEDLINE | ID: mdl-28639108

ABSTRACT

Hepatic fibrosis is an extracellular matrix deposition by hepatic stellate cells (HSC). Fibrosis can be caused by iron, which will lead to hydroxyl radical production and cell damage. Fructose-1,6-bisphosphate (FBP) has been shown to deliver therapeutic effects in many pathological situations. In this work, we aimed to test the effects of FBP in HSC cell line, GRX, exposed to an excess of iron (Fe). The Fe-treatment increased cell proliferation and FBP reversed this effect, which was not due to increased necrosis, apoptosis or changes in cell cycle. Oil Red-O staining showed that FBP successfully increased lipid content and lead GRX cells to present characteristics of quiescent HSC. Fe-treatment decreased PPAR-γ expression and increased Col-1 expression. Both effects were reversed by FBP which also decreased TGF-ß1 levels in comparison to both control and Fe groups. FBP, also, did not present scavenger activity in the DPPH assay. The treatment with FBP resulted in decreased proliferation rate, Col-1 expression and TGF-ß1 release by HSC cells. Furthermore, activated PPAR-γ and increased lipid droplets induce cells to become quiescent, which is a key event to reversion of hepatic fibrosis. FBP also chelates iron showing potential to improve Cell redox state.


Subject(s)
Ferrous Compounds/antagonists & inhibitors , Fructosediphosphates/pharmacology , Hepatic Stellate Cells/drug effects , Iron Chelating Agents/pharmacology , Animals , Biphenyl Compounds/chemistry , Cell Line , Cell Survival/drug effects , Collagen Type I/genetics , Collagen Type I/metabolism , Ferrous Compounds/pharmacology , Gene Expression Regulation , Hepatic Stellate Cells/cytology , Hepatic Stellate Cells/metabolism , Lipid Droplets/drug effects , Lipid Droplets/metabolism , Mice , Oxidation-Reduction , PPAR gamma/genetics , PPAR gamma/metabolism , Picrates/chemistry , Signal Transduction , Transforming Growth Factor beta1/genetics , Transforming Growth Factor beta1/metabolism
4.
Arch Pharm (Weinheim) ; 350(7)2017 Jul.
Article in English | MEDLINE | ID: mdl-28379621

ABSTRACT

A series of Mannich bases of benzimidazole derivatives having a phenolic group were designed to assess their anticholinesterase and antioxidant activities. The acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) inhibitory activities were evaluated in vitro by using Ellman's method. According to the activity results, all of the compounds exhibited moderate to good AChE inhibitory activity (except for 2a), with IC50 values ranging from 0.93 to 10.85 µM, and generally displayed moderate BuChE inhibitory activity. Also, most of the compounds were selective against BuChE. Compound 4b was the most active molecule on the AChE enzyme and also selective. In addition, we investigated the antioxidant effects of the synthesized compounds against FeCl2 /ascorbic acid-induced oxidative stress in the rat brain in vitro, and the activity results showed that most of the compounds are effective as radical scavengers. Molecular docking studies and molecular dynamics simulations were also carried out.


Subject(s)
Antioxidants/pharmacology , Benzimidazoles/pharmacology , Cholinesterase Inhibitors/pharmacology , Mannich Bases/pharmacology , Molecular Docking Simulation , Acetylcholinesterase/metabolism , Animals , Antioxidants/chemical synthesis , Antioxidants/chemistry , Ascorbic Acid/antagonists & inhibitors , Ascorbic Acid/pharmacology , Benzimidazoles/chemistry , Brain/drug effects , Brain/metabolism , Butyrylcholinesterase/metabolism , Cholinesterase Inhibitors/chemical synthesis , Cholinesterase Inhibitors/chemistry , Dose-Response Relationship, Drug , Electrophorus , Ferrous Compounds/antagonists & inhibitors , Ferrous Compounds/pharmacology , Horses , Mannich Bases/chemistry , Oxidative Stress/drug effects , Rats , Rats, Sprague-Dawley , Reactive Oxygen Species/metabolism , Structure-Activity Relationship
5.
Colloids Surf B Biointerfaces ; 142: 46-54, 2016 Jun 01.
Article in English | MEDLINE | ID: mdl-26925725

ABSTRACT

Copper ferrite (CuFe2O4) nanoparticles (NPs) are important magnetic materials currently under research due to their applicability in nanomedicine. However, information concerning the biological interaction of copper ferrite NPs is largely lacking. In this study, we investigated the cellular response of copper ferrite NPs in human breast cancer (MCF-7) cells. Copper ferrite NPs were prepared by co-precipitation technique with the thermal effect. Prepared NPs were characterized by X-ray diffraction (XRD), field emission transmission electron microscopy (FETEM) and dynamic light scattering (DLS). Characterization data showed that copper ferrite NPs were crystalline, spherical with smooth surfaces and average diameter of 15nm. Biochemical studies showed that copper ferrite NPs induce cell viability reduction and membrane damage in MCF-7 cells and degree of induction was dose- and time-dependent. High SubG1 cell population during cell cycle progression and MMP loss with a concomitant up-regulation of caspase-3 and caspase-9 genes suggested that copper ferrite NP-induced cell death through mitochondrial pathway. Copper ferrite NP was also found to induce oxidative stress in MCF-7 cells as indicated by reactive oxygen species (ROS) generation and glutathione depletion. Cytotoxicity due to copper ferrite NPs exposure was effectively abrogated by N-acetyl-cysteine (ROS scavenger) suggesting that oxidative stress could be the plausible mechanism of copper ferrite NPs toxicity. Further studies are underway to explore the toxicity mechanisms of copper ferrite NPs in different types of human cells. This study warrants further generation of extensive biointeraction data before their application in nanomedicine.


Subject(s)
Antineoplastic Agents/pharmacology , Apoptosis/drug effects , Copper/pharmacology , Ferrous Compounds/pharmacology , Magnetite Nanoparticles/chemistry , Oxidative Stress/drug effects , Acetylcysteine/pharmacology , Antineoplastic Agents/chemistry , Caspase 3/genetics , Caspase 3/metabolism , Caspase 9/genetics , Caspase 9/metabolism , Cell Cycle/drug effects , Cell Membrane/drug effects , Cell Survival/drug effects , Copper/chemistry , Dose-Response Relationship, Drug , Ferrous Compounds/antagonists & inhibitors , Ferrous Compounds/chemistry , Free Radical Scavengers/pharmacology , Gene Expression , Glutathione/antagonists & inhibitors , Glutathione/metabolism , Humans , L-Lactate Dehydrogenase/genetics , L-Lactate Dehydrogenase/metabolism , MCF-7 Cells , Magnetite Nanoparticles/ultrastructure , Membrane Potential, Mitochondrial/drug effects , Mitochondria/drug effects , Mitochondria/metabolism , Particle Size , Reactive Oxygen Species/agonists , Reactive Oxygen Species/metabolism
6.
J Oleo Sci ; 64(7): 775-82, 2015.
Article in English | MEDLINE | ID: mdl-25994557

ABSTRACT

The inhibition of enzymes involved in the breakdown of carbohydrates is considered a therapeutic approach to the management of type-2 diabetes. This study sought to investigate the effects of essential oil from clove bud on α-amylase and α-glucosidase activities. Essential oil from clove bud was extracted by hydrodistillation, dried with anhydrous Na2SO4 and characterized using gas chromatography-mass spectrometry (GC-MS). The effects of the essential oil on α-amylase and α-glucosidase activities were investigated. The antioxidant properties of the oil and the inhibition of Fe(2+) and sodium nitroprusside-induced malondialdehyde (MDA) production in rats pancreas homogenate were also carried out. The essential oil inhibited α-amylase (EC50=88.9 µl/L) and α-glucosidase (EC50=71.94 µl/L) activities in a dose-dependent manner. Furthermore, the essential oil inhibited Fe(2+) and SNP-induced MDA production and exhibited antioxidant activities through their NO*, OH*, scavenging and Fe(2+)- chelating abilities. The total phenolic and flavonoid contents of the essential oil were 12.95 mg/g and 6.62 mg/g respectively. GC-MS analysis revealed the presence of α-pinene, ß-pinene, neral, geranial, gamma terpinene, cis-ocimene, allo ocimene, 1,8-cineole, linalool, borneol, myrcene and pinene-2-ol in significant amounts. Furthermore, the essential oils exhibited antioxidant activities as typified by hydroxyl (OH) and nitric oxide (NO)] radicals scavenging and Fe(2+)-chelating abilities. The inhibition of α-amylase and α-glucosidase activities, inhibition of pro-oxidant induced lipid peroxidation in rat pancreas and antioxidant activities could be possible mechanisms for the use of the essential oil in the management and prevention of oxidative stress induced type-2 diabetes.


Subject(s)
Antioxidants , Clove Oil/pharmacology , Diabetes Mellitus, Type 2/enzymology , Diabetes Mellitus, Type 2/etiology , Lipid Peroxidation/drug effects , Oils, Volatile/pharmacology , Pancreas/metabolism , Syzygium/chemistry , alpha-Amylases/metabolism , alpha-Glucosidases/metabolism , Animals , Clove Oil/chemistry , Clove Oil/isolation & purification , Depression, Chemical , Dose-Response Relationship, Drug , Ferrous Compounds/antagonists & inhibitors , Free Radical Scavengers , In Vitro Techniques , Iron Chelating Agents , Malondialdehyde/metabolism , Nitroprusside , Oils, Volatile/chemistry , Oils, Volatile/isolation & purification , Oxidative Stress , Rats , Reactive Oxygen Species
7.
Bioorg Chem ; 50: 26-33, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23941993

ABSTRACT

This study was designed to determine and compare the antioxidant effects of synthetic organoselenium compounds. In experimental trials three different diselenides were used: bis(2-hydroxyphenyl) diselenide, bis{[2-(4-hydroxybenzyl)imino]phenyl} diselenide and bis[2-(4-methylphenylsulfonylamino)phenyl] diselenide. The compounds were screened for antioxidant activities in human blood under oxidation stress conditions. Oxidative stress was induced in vitro in human blood platelet samples and in plasma by 0.1 mM peroxynitrite (ONOO(-)) or by Fe(2+). In experimental trials the levels of chosen oxidative stress markers (TBARS, O2(-), and protein carbonyl groups) were significantly decreased by the action of the tested compounds. The antioxidative properties and the changes in proteins and lipids in the presence of new synthesized selenoorganic compounds were studied in vitro and compared with activity of ebselen (2-phenyl-1,2-benzisoselenazol-3(2H)-one)--a classical antioxidant, well known as the most important glutathione peroxidase mimetic agent. Our results indicate that the tested diselenides have distinctly protective effects against oxidative alterations of biomolecules caused by ONOO(-) and Fe(2+) in blood platelets and in plasma. Therefore it seems that not only ebselen with a wide spectrum of therapeutic actions but also other organoselenium compounds can be considered in the future as active pharmacological agents.


Subject(s)
Antioxidants/pharmacology , Blood Platelets/chemistry , Organoselenium Compounds/blood , Organoselenium Compounds/pharmacology , Antioxidants/analysis , Antioxidants/chemical synthesis , Antioxidants/chemistry , Dose-Response Relationship, Drug , Ferrous Compounds/antagonists & inhibitors , Ferrous Compounds/pharmacology , Humans , Organoselenium Compounds/chemical synthesis , Organoselenium Compounds/chemistry , Oxidative Stress/drug effects , Peroxynitrous Acid/antagonists & inhibitors , Peroxynitrous Acid/pharmacology , Structure-Activity Relationship
8.
Neurotox Res ; 24(1): 71-9, 2013 Jul.
Article in English | MEDLINE | ID: mdl-23184650

ABSTRACT

Iron accumulation is considered to be involved in the pathogenesis of Parkinson's disease (PD). Our previous studies have observed that Rg1, a major pharmacologically active ingredient from Ginseng, could protect dopaminergic neurons by reducing nigral iron levels through regulating the expression of iron transporters in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced PD mice. The aim of this study is to investigate other mechanism involved in the cytoprotection of Rg1 against iron-induced neurotoxicity in human neuroblastoma SK-N-SH cells. Significant rescue of Rg1 on cell viability against 100 µM ferrous iron-induced neurotoxicity was observed. Upregulation of heme oxygenase-1 (HO-1) and Cu-Zn superoxide dismutase (Cu/Zn SOD) were observed in Rg1 pretreated group. Moreover, Rg1 pretreatment induces Nrf2 nuclear translocation, which is upstream of HO-1 expression, and activated PI3K/Akt pathway was also observed in Rg1 pretreated group. This could antagonize iron-induced increase in intracellular reactive oxygen species and decrease in mitochondrial transmembrane potential. These results suggest that the neuroprotective effects of Rg1 against iron toxicity are attributed to the anti-oxidative properties by activating Akt/Nrf2 pathway and increasing Nrf2-induced expression of HO-1 and Cu/Zn SOD.


Subject(s)
Ferrous Compounds/antagonists & inhibitors , Ginsenosides/pharmacology , Heme Oxygenase-1/metabolism , Iron/toxicity , NF-E2-Related Factor 2/metabolism , Neuroprotective Agents/pharmacology , Proto-Oncogene Proteins c-akt/metabolism , Cell Nucleus/drug effects , Cell Nucleus/metabolism , Cell Survival/drug effects , Down-Regulation , Ferrous Compounds/toxicity , Humans , Membrane Potential, Mitochondrial/drug effects , Phosphatidylinositol 3-Kinases/metabolism , Reactive Oxygen Species/metabolism , Superoxide Dismutase/metabolism , Up-Regulation
9.
Neurotoxicol Teratol ; 33(5): 538-47, 2011.
Article in English | MEDLINE | ID: mdl-21763768

ABSTRACT

Kynurenic acid (KYNA) is an endogenous metabolite of the kynurenine pathway for tryptophan degradation and an antagonist of both N-methyl-D-aspartate (NMDA) and alpha-7 nicotinic acetylcholine (α7nACh) receptors. KYNA has also been shown to scavenge hydroxyl radicals (OH) under controlled conditions of free radical production. In this work we evaluated the ability of KYNA to scavenge superoxide anion (O(2)(-)) and peroxynitrite (ONOO(-)). The scavenging ability of KYNA (expressed as IC(50) values) was as follows: OH=O(2)(-)>ONOO(-). In parallel, the antiperoxidative and scavenging capacities of KYNA (0-150 µM) were tested in cerebellum and forebrain homogenates exposed to 5 µM FeSO(4) and 2.5 mM 3-nitropropionic acid (3-NPA). Both FeSO(4) and 3-NPA increased lipid peroxidation (LP) and ROS formation in a significant manner in these preparations, whereas KYNA significantly reduced these markers. Reactive oxygen species (ROS) formation were determined in the presence of FeSO(4) and/or KYNA (0-100 µM), both at intra and extracellular levels. An increase in ROS formation was induced by FeSO(4) in forebrain and cerebellum in a time-dependent manner, and KYNA reduced this effect in a concentration-dependent manner. To further know whether the effect of KYNA on oxidative stress is independent of NMDA and nicotinic receptors, we also tested KYNA (0-100 µM) in a biological preparation free of these receptors - defolliculated Xenopus laevis oocytes - incubated with FeSO(4) for 1 h. A 3-fold increase in LP and a 2-fold increase in ROS formation were seen after exposure to FeSO(4), whereas KYNA attenuated these effects in a concentration-dependent manner. In addition, the in vivo formation of OH evoked by an acute infusion of FeSO(4) (100 µM) in the rat striatum was estimated by microdialysis and challenged by a topic infusion of KYNA (1 µM). FeSO(4) increased the striatal OH production, while KYNA mitigated this effect. Altogether, these data strongly suggest that KYNA, in addition to be a well-known antagonist acting on nicotinic and NMDA receptors, can be considered as a potential endogenous antioxidant.


Subject(s)
Antioxidants/pharmacology , Free Radical Scavengers/pharmacology , Kynurenic Acid/pharmacology , Oxidative Stress/drug effects , Animals , Antioxidants/administration & dosage , Cells, Cultured , Cerebellum/drug effects , Cerebellum/metabolism , Corpus Striatum/drug effects , Corpus Striatum/metabolism , Dose-Response Relationship, Drug , Ferrous Compounds/antagonists & inhibitors , Ferrous Compounds/pharmacology , Hydroxides/metabolism , Kynurenic Acid/administration & dosage , Lipid Peroxidation/drug effects , Male , Microinjections , Nitro Compounds/antagonists & inhibitors , Nitro Compounds/pharmacology , Oocytes/metabolism , Propionates/antagonists & inhibitors , Propionates/pharmacology , Prosencephalon/drug effects , Prosencephalon/metabolism , Rats , Rats, Wistar , Reactive Oxygen Species/metabolism , Xenopus laevis
10.
Neurotox Res ; 20(1): 26-31, 2011 Jul.
Article in English | MEDLINE | ID: mdl-20809179

ABSTRACT

Iron accumulation in brain is associated with a number of common neurodegenerative disorders. N-ß-alanyl-5-S-glutathionyl-3,4-dihydroxyphenylalanine (5-S-GAD), a novel catechol derivative, was isolated from adult flesh fly as a defense substance. We examined the effect of 5-S-GAD on Fe²+-induced lipid peroxidation and cell death in PC12 cells. Treatment of PC12 cells with Fe²+ (1-20 µM) for 24 h induced lipid peroxidation and cell death in a dose-dependent manner. Butylated hydroxyanisole and α-tocopherol inhibited Fe²+-induced lipid peroxidation and cell death. 5-S-GAD inhibited Fe²+-induced lipid peroxidation and cell death. 5-S-GAD protected PC12 cells from Fe²+-induced cell death possibly by blocking lipid peroxidation.


Subject(s)
Cell Death/drug effects , Dihydroxyphenylalanine/analogs & derivatives , Ferrous Compounds/antagonists & inhibitors , Glutathione/analogs & derivatives , Lipid Peroxidation/drug effects , Neurons/physiology , Animals , Butylated Hydroxyanisole/pharmacology , Cell Death/physiology , Dihydroxyphenylalanine/pharmacology , Dose-Response Relationship, Drug , Ferrous Compounds/pharmacology , Glutathione/pharmacology , Neurons/drug effects , PC12 Cells , Rats , Thiobarbituric Acid Reactive Substances/metabolism , Tocopherols/pharmacology
11.
Chem Biol Interact ; 182(1): 52-8, 2009 Nov 10.
Article in English | MEDLINE | ID: mdl-19589335

ABSTRACT

As an extension of our previous work we not only evaluated the relationship between acidosis and lipid peroxidation in rat's kidney homogenate, but also determined for the first time the potential anti-oxidant activity of diphenyl diselenide, diphenyl ditelluride and ebselen at a range of pH values (7.4-5.4). Because of the pH dependency of iron redox cycling, pH and iron need to be well controlled and for the reason we tested a number of pH values (from 7.4 to 5.4) to get a closer idea about the role of iron under various pathological conditions. Acidosis increased rate of lipid peroxidation in the absence Fe (II) in kidney homogenates especially at pH 5.4. This higher extent of lipid peroxidation can be explained by; the mobilized iron which may come from reserves where it is weakly bound. Addition of iron (Fe) chelator desferoxamine (DFO) to reaction medium completely inhibited the peroxidation processes at all studied pH values including acidic values (5.8-5.4). In the presence of Fe (II) acidosis also enhanced detrimental effect of Fe (II) especially at pH (6.4-5.4). Diphenyl diselenide significantly protected lipid peroxidation at all studied pH values, while ebselen offered only a small statistically non-significant protection. The highest anti-oxidant potency was observed for diphenyl ditelluride. These differences in potencies were explained by the mode of action of these compounds using their catalytic anti-oxidant cycles. However, changing the pH of the reaction medium did not alter the anti-oxidant activity of the tested compounds. This study provides evidence for acidosis catalyzed oxidative stress in kidney homogenate and for the first time anti-oxidant potential of diphenyl diselenide and diphenyl ditelluride not only at physiological pH but also at a range of acidic values.


Subject(s)
Antioxidants/pharmacology , Azoles/pharmacology , Benzene Derivatives/pharmacology , Kidney/drug effects , Organometallic Compounds/pharmacology , Organoselenium Compounds/pharmacology , Oxidative Stress/drug effects , Animals , Deferoxamine/pharmacology , Ferrous Compounds/antagonists & inhibitors , Ferrous Compounds/pharmacology , Hydrogen-Ion Concentration , Isoindoles , Kidney/metabolism , Lipid Peroxidation/drug effects , Male , Oxidation-Reduction , Oxidative Stress/physiology , Rats , Rats, Wistar , Siderophores/pharmacology , Thiobarbituric Acid Reactive Substances/metabolism
12.
Nutr Neurosci ; 12(1): 35-42, 2009 Feb.
Article in English | MEDLINE | ID: mdl-19178790

ABSTRACT

The antiperoxidative properties of alpha-mangostin, a xanthone isolated from mangosteen fruit, were tested for the first time in nerve tissue exposed to different toxic insults. Two reliable biological preparations (rat brain homogenates and synaptosomal P2 fractions) were exposed to the toxic actions of a free radical generator (ferrous sulfate), an excitotoxic agent (quinolinate), and a mitochondrial toxin (3-nitropropionate). alpha-Mangostin decreased the lipoperoxidative action of FeSO(4) in both preparations in a concentration-dependent manner, and completely abolished the peroxidative effects of quinolinate, 3-nitropropionate and FeSO(4) + quinolinate at all concentrations tested. Interestingly, when tested alone in brain homogenates, alpha-mangostin significantly decreased the lipoperoxidation even below basal levels. alpha-Mangostin also prevented the decreased reductant capacity of mitochondria in synaptosomal fractions. Our results suggest that alpha-mangostin exerts a robust antiperoxidative effect in brain tissue preparations probably through its properties as a free radical scavenger. In light of these findings, this antioxidant should be tested in other neurotoxic models involving oxidative stress.


Subject(s)
Antioxidants/pharmacology , Brain/metabolism , Oxidative Stress/drug effects , Xanthones/pharmacology , Animals , Brain/drug effects , Brain/ultrastructure , Dose-Response Relationship, Drug , Ferrous Compounds/antagonists & inhibitors , Ferrous Compounds/pharmacology , Lipid Peroxidation/drug effects , Male , Mitochondria/drug effects , Mitochondria/physiology , Nitro Compounds/antagonists & inhibitors , Nitro Compounds/pharmacology , Propionates/antagonists & inhibitors , Propionates/pharmacology , Quinolinic Acid/antagonists & inhibitors , Quinolinic Acid/pharmacology , Rats , Rats, Wistar , Synaptosomes/drug effects , Synaptosomes/metabolism , Synaptosomes/ultrastructure , Thiobarbituric Acid Reactive Substances/analysis
13.
Am J Chin Med ; 34(4): 707-20, 2006.
Article in English | MEDLINE | ID: mdl-16883640

ABSTRACT

Glossogyne tenuifolia (Labill) Cass. (Compositae) is a special medicinal plant in the Pescadores Islands. Ethanolic, cold and hot water extracts were prepared from the dried herb and their antioxidant properties and components were studied. Ascorbic acid, alpha-tocopherol, butylated hydroxyanisole, citric and ethylenediaminetetraacetic acids were used in assays for comparison. With regard to EC(50) values in antioxidant activity, ethanolic and hot water extracts (0.08 and 0.09 mg/ml) were much more effective than the cold water extract (0.76 mg/ml). At 1.0 mg/ml, reducing capacities were 1.57, 0.31 and 1.04 for ethanolic, cold water and hot water extracts, respectively. Scavenging abilities on 1,1-diphenyl-2-picrylhydrazyl radicals were in descending order: ethanolic > cold water > hot water extracts. At 20 mg/ml, the hot water extract chelated all hydroxyl ions (100%) whereas the scavenging ability of the cold water extract was 68.86%. Chelating abilities on ferrous ions were in descending order: cold water > hot water > ethanolic extracts. Phenols were found to be the major antioxidant components. All EC(50) values were below 20 mg/ml, and some even below 0.1 mg/ml, indicating that all three extracts from G. tenuifolia were rich in antioxidant properties.


Subject(s)
Antioxidants/chemistry , Asteraceae/chemistry , Antioxidants/isolation & purification , Antioxidants/pharmacology , Ascorbic Acid/analysis , Biphenyl Compounds/antagonists & inhibitors , Biphenyl Compounds/chemistry , Chromatography, High Pressure Liquid/methods , Dose-Response Relationship, Drug , Ferrous Compounds/antagonists & inhibitors , Ferrous Compounds/chemistry , Free Radical Scavengers/chemistry , Free Radical Scavengers/isolation & purification , Free Radical Scavengers/pharmacology , Hydrazines/antagonists & inhibitors , Hydrazines/chemistry , Hydroxyl Radical/antagonists & inhibitors , Hydroxyl Radical/chemistry , Iron Chelating Agents/chemistry , Iron Chelating Agents/isolation & purification , Iron Chelating Agents/pharmacology , Oxidation-Reduction/drug effects , Picrates , Plant Extracts/chemistry , Plant Extracts/isolation & purification , Plant Extracts/pharmacology , Tocopherols/analysis , beta Carotene/analysis
14.
Bioorg Med Chem Lett ; 14(24): 5971-4, 2004 Dec 20.
Article in English | MEDLINE | ID: mdl-15546710
15.
Mutat Res ; 483(1-2): 57-64, 2001 Nov 01.
Article in English | MEDLINE | ID: mdl-11600133

ABSTRACT

We have previously shown that simultaneous exposure of rat lymphocytes to iron ions and 50Hz magnetic field (MF) caused an increase in the number of cells with DNA strand breaks. Although the mechanism of MF-induced DNA damage is not known, we suppose that it involves free radicals. In the present study, to confirm our hypothesis, we have examined the effect of melatonin, an established free radicals scavenger, on DNA damage in rat peripheral blood lymphocytes exposed in vitro to iron ions and 50Hz MF. The alkaline comet assay was chosen for the assessment of DNA damage. During pre-incubation, part of the cell samples were supplemented with melatonin (0.5 or 1.0mM). The experiments were performed on the cell samples incubated for 3h in Helmholtz coils at 7mT 50Hz MF. During MF exposure, some samples were treated with ferrous chloride (FeCl2, 10microg/ml), while the rest served as controls. A significant increase in the number of cells with DNA damage was found only after simultaneous exposure of lymphocytes to FeCl2 and 7mT 50Hz MF, compared to the control samples or those incubated with FeCl2 alone. However, when the cells were treated with melatonin and then exposed to iron ions and 50Hz MF, the number of damaged cells was significantly reduced, and the effect depended on the concentration of melatonin. The reduction reached about 50% at 0.5mM and about 100% at 1.0mM. Our results indicate that melatonin provides protection against DNA damage in rat lymphocytes exposed in vitro to iron ions and 50Hz MF (7mT). Therefore, it can be suggested that free radicals may be involved in 50Hz magnetic field and iron ions-induced DNA damage in rat blood lymphocytes. The future experimental studies, in vitro and in vivo, should provide an answer to the question concerning the role of melatonin in the free radical processes in the power frequency magnetic field.


Subject(s)
DNA Damage , Ferrous Compounds/toxicity , Lymphocytes/drug effects , Lymphocytes/metabolism , Magnetics/adverse effects , Melatonin/pharmacology , Animals , Cations, Divalent/antagonists & inhibitors , Cations, Divalent/toxicity , Comet Assay , Ferrous Compounds/antagonists & inhibitors , Free Radical Scavengers/pharmacology , In Vitro Techniques , Male , Rats , Rats, Wistar
16.
Free Radic Biol Med ; 28(7): 1068-78, 2000 Apr 01.
Article in English | MEDLINE | ID: mdl-10832068

ABSTRACT

Reactive oxygen species are thought to induce cellular damage and to play a pathological role in several human diseases. Tetradecylthioacetic acid (TTA) was previously reported to prevent the oxidative modification of low-density lipoprotein (LDL) particles and to act as an antioxidant. In this study we present a new fatty acid analogue, namely tetradecylselenoacetic acid (TSA), in which the sulfur atom of TTA is replaced by a selenium atom. TSA was more potent than TTA in increasing the lag time before the onset of LDL oxidation and this effect was dose dependent. TTA and TSA were shown to reduce the iron-ascorbate-induced microsomal lipid peroxidation, TSA being more efficient than TTA. TTA and TSA, in the presence of iron, interacted with the superoxide radical as assessed by direct and indirect testing methods. TSA like TTA failed to scavenge 1.1-diphenyl-2-picrylhydrazyl radicals. TSA bound copper ions as shown by the wavelength spectra measurement. These results suggest that TTA and TSA exert their antioxidant capacity by interaction with copper or iron ions in radical scavenging, TSA being more potent than TTA. Nevertheless, a chelating effect resulting in chemically inactive metal ions cannot be excluded.


Subject(s)
Bepridil/analogs & derivatives , Free Radical Scavengers/metabolism , Free Radical Scavengers/toxicity , Lipid Peroxidation/drug effects , Organometallic Compounds/metabolism , Organometallic Compounds/toxicity , Picrates , Sulfides/metabolism , Sulfides/toxicity , Superoxides/metabolism , Animals , Antioxidants/metabolism , Antioxidants/toxicity , Ascorbic Acid/antagonists & inhibitors , Ascorbic Acid/metabolism , Bepridil/metabolism , Biphenyl Compounds , Copper/metabolism , Cytochrome c Group/metabolism , Electrophoresis, Agar Gel , Fatty Acids/metabolism , Fatty Acids/toxicity , Ferrous Compounds/antagonists & inhibitors , Ferrous Compounds/metabolism , Iron/metabolism , Lipoproteins, LDL/metabolism , Male , Microsomes, Liver/drug effects , Microsomes, Liver/metabolism , Palmitic Acid/metabolism , Rats , Rats, Wistar
17.
J Neural Transm (Vienna) ; 106(9-10): 835-48, 1999.
Article in English | MEDLINE | ID: mdl-10599866

ABSTRACT

We investigated the effect of nitric oxide (NO) on iron-induced neuronal damage. Incubation of PC12 cells after the addition of FeCl2 induced rapid increases (within 1 hr) in lipid peroxidation and a concentration (0.1-2 mM)-dependent decrease in cell viability at 48 hr, both of which were blocked by deferoxamine and 2-methyl-6-(p-methoxyphenyl)-3,7-dihydroimidazo[1,2-a]pyrazine-3-o ne hydrochloride (MCLA) (a superoxide scavenger) but not by mannitol (a hydroxyl radical scavenger). Iron-induced cytotoxicity was also antagonized by superoxide dismutase with catalase. On the other hand, the NO donors S-nitroso-N-acetylpenicillamine (SNAP), 3-¿(+/-)-(E)-ethyl-2'-[(E)-hydroxylamino]-5-nitro-3-hexenecarbo moyl¿-pyridine (NOR-4), and 2,2'-(hydroxynitrosohydrazono)bis-ethanamine (NOC-18) decreased cell viability 48 hr after addition without increasing lipid peroxidation. However, when added with 1 mM FeCl2, NO donors including NOC-18, SNAP and NOR-4 (0.1-1 mM) inhibited lipid peroxidation in a concentration-dependent manner and suppressed cell death at lower concentrations. Addition of MCLA and NOC-18 also suppressed decreases in iron-induced [3H]thymidine incorporation. In rat brain homogenate, NOC-18 and SNAP both suppressed iron-induced lipid peroxidation. These findings suggest that NO has a dual effect on neuronal viability and can act as an antioxidant which protects neurons from iron-induced damage.


Subject(s)
Ferrous Compounds/pharmacology , Free Radical Scavengers/pharmacology , Imidazoles/pharmacology , Lipid Peroxidation/drug effects , Neurons/drug effects , Nitric Oxide Donors/pharmacology , Pyrazines/pharmacology , Animals , Cell Count/drug effects , Cerebral Cortex/drug effects , Cerebral Cortex/metabolism , Ferrous Compounds/antagonists & inhibitors , Lipid Peroxidation/physiology , Male , Neurons/metabolism , PC12 Cells/drug effects , Rats , Rats, Sprague-Dawley , Thiobarbituric Acid Reactive Substances/metabolism , Time Factors
18.
Jpn J Pharmacol ; 81(1): 7-11, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10580364

ABSTRACT

Mexiletine is a class Ib antiarrhythmic drug used in the treatment of ventricular arrhythmias. The Na+ channel blocker mexiletine inhibits calcium influx in cells via decreasing reverse operation of the Na+-Ca2+ exchanger. Thus this drug is shown to protect the CNS white matter against anoxic/ischemic injury. The aim of our study was to investigate if this drug could act as an antioxidant drug as well. The antioxidant action of this drug was studied under different oxidant conditions in vitro, and thiobarbituric acid-reactive substances were measured to follow lipid peroxidation. Mexiletine inhibited iron-ascorbate-H2O2-induced lipid peroxidation in brain membranes, liver microsomes and phospholipid liposomes, being most effective in brain membranes. The inhibition was dose- and time-dependent. Mexiletine also inhibited copper-ascorbate-H2O2-induced lipid peroxidation but to a lesser extent. It is concluded that mexiletine has a dual effect toward oxidative injury in brain, both by inhibiting Na+-Ca2+ exchanger-dependent Ca2+ influx and by acting as an inhibitor of lipid peroxidation. However, as this drug is effective at millimolar concentrations, it should be considered less active than natural antioxidants that are effective at micromolar concentrations.


Subject(s)
Anti-Arrhythmia Agents/pharmacology , Antioxidants/pharmacology , Brain/drug effects , Brain/metabolism , Mexiletine/pharmacology , Animals , Ascorbic Acid/antagonists & inhibitors , Ascorbic Acid/toxicity , Dose-Response Relationship, Drug , Ferrous Compounds/antagonists & inhibitors , Ferrous Compounds/toxicity , Hydrogen Peroxide/antagonists & inhibitors , Hydrogen Peroxide/toxicity , Lipid Peroxidation/drug effects , Liposomes , Male , Microsomes, Liver/drug effects , Microsomes, Liver/metabolism , Oxidants/toxicity , Phosphatidylserines/metabolism , Rats , Rats, Wistar , Sodium Channel Blockers , Sodium-Calcium Exchanger/antagonists & inhibitors
19.
Biochemistry ; 38(50): 16529-38, 1999 Dec 14.
Article in English | MEDLINE | ID: mdl-10600114

ABSTRACT

The mechanism of inhibition of porcine leukocyte 12-lipoxygenase by 4-(2-oxapentadeca-4-yne)phenylpropanoic acid (OPP) was investigated. This compound is selective for the leukocyte form of the 12-lipoxygenase and inhibits the purified recombinant enzyme with an IC(50) value of approximately 2 microM. OPP induced a concentration-dependent lag phase in the oxygenation of arachidonic acid and decreased the maximal rate of reaction. Addition of the fatty acid hydroperoxide 13(S)-hydroperoxyoctadecadienoic acid (13-HPODE) to the reaction greatly reduced the OPP-induced lag. Lineweaver-Burk analysis of the effect of OPP on 12-lipoxygenase kinetics with arachidonic acid indicated that it was a mixed-type inhibitor. OPP was not metabolized by 12-lipoxygenase as evidenced by its quantitative recovery from incubations with stoichiometric amounts of enzyme and 13-HPODE or arachidonic acid. OPP inhibited the pseudoperoxidase activity of the enzyme with 13-HPODE and the reducing agent, BWA137C. Lineweaver-Burk analysis of the effect of OPP on pseudoperoxidase kinetics suggested that OPP was competitive with 13-HPODE. Single-turnover experiments indicated that OPP inhibited the reduction of 13-HPODE by a stoichiometric amount of ferrous 12-lipoxygenase. Addition of 13-HPODE shortened the OPP-induced lag phase but did not affect the maximal rate of enzyme activity. In addition, OPP had no effect on total product formation in either the presence or the absence of 5 microM 13-HPODE when the reaction was allowed to go to completion. All of these observations are consistent with a model for inhibition of 12-lipoxygenase activity in which OPP slows the oxidation of the inactive ferrous enzyme to the active ferric enzyme and competes with arachidonic acid for the ferric enzyme.


Subject(s)
Arachidonate 12-Lipoxygenase/chemistry , Leukocytes/enzymology , Lipoxygenase Inhibitors , Lipoxygenase Inhibitors/chemistry , Phenylpropionates/chemistry , Animals , Arachidonate 12-Lipoxygenase/genetics , Chromatography, High Pressure Liquid , Ferric Compounds/antagonists & inhibitors , Ferric Compounds/chemistry , Ferrous Compounds/antagonists & inhibitors , Ferrous Compounds/chemistry , Isoenzymes/antagonists & inhibitors , Isoenzymes/chemistry , Isoenzymes/genetics , Linoleic Acids/antagonists & inhibitors , Linoleic Acids/chemistry , Lipid Peroxides/antagonists & inhibitors , Lipid Peroxides/chemistry , Lipoxygenase Inhibitors/pharmacology , Oxidation-Reduction , Peroxidases/antagonists & inhibitors , Peroxidases/chemistry , Phenylpropionates/pharmacology , Recombinant Proteins/antagonists & inhibitors , Recombinant Proteins/chemistry , Swine
20.
Biochemistry ; 37(25): 8980-6, 1998 Jun 23.
Article in English | MEDLINE | ID: mdl-9636040

ABSTRACT

The effects of phosphorylation at Ser40 of rat tyrosine hydroxylase on the affinities of catechols have been determined with both the ferric and ferrous forms of the enzyme. Phosphorylation had no effect on the Ki value for the inhibition of the ferrous enzyme by either dopamine or DOPA when the initial rate of turnover was measured in assays. However, phosphorylation of the ferric enzyme resulted in a 17-fold decrease in affinity for DOPA and a 300-fold decrease in the affinity for dopamine, while the affinity for dihydroxynaphthalene was unchanged. The changes in binding affinity for the two catecholamines were almost exclusively due to large increases in the dissociation rate constants upon phosphorylation. These results support a novel mechanism for regulation in which phosphorylation affects binding of catecholamines to the catalytically inactive ferric form of the tyrosine hydroxylase.


Subject(s)
Catecholamines/metabolism , Serine/metabolism , Tyrosine 3-Monooxygenase/metabolism , Animals , Catecholamines/pharmacology , Dihydroxyphenylalanine/metabolism , Dopamine/metabolism , Ferric Compounds/antagonists & inhibitors , Ferric Compounds/metabolism , Ferrous Compounds/antagonists & inhibitors , Ferrous Compounds/metabolism , Oxidation-Reduction/drug effects , Phosphorylation , Protein Binding , Protein Processing, Post-Translational , Rats , Tyrosine 3-Monooxygenase/antagonists & inhibitors
SELECTION OF CITATIONS
SEARCH DETAIL
...